Jazz Pharmaceuticals plc DSO Ratio 2011-2026 | JAZZ

Annual DSO Ratio Jazz Pharmaceuticals plc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
66.2	63.8	64.6	60.6	56.6	58.1	60.1	50.9	50.5	57.4	57.8	58	52.2	47	46.1

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
66.2	46.1	56.7

Quarterly DSO Ratio Jazz Pharmaceuticals plc

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
59.9	59.6	70	61.5	62.6	67.5	58.1	58.8	65.2	-	29.2	28	63.7	-	54.8	55.9	60.9	54.4	60.2	64.3	64.2	55.8	60.4	60.8	55.6	50.5	51.3	48.1	50.1	46.9	49.7	51.9	55.6	53.9	57.1	56.1	60.3	56.1	56.1	57.3	58.4	51.8	55.5	58.4	57.5	48.3	49	54.7	46.6	37.5	39.2	55.4	48.9	37.5	42.8	48.6	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
70	28	54.1

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Xeris Pharmaceuticals XERS	57.2	$ 6.03	-1.55 %	$ 885 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
UroGen Pharma Ltd. URGN	88.7	$ 19.2	-11.52 %	$ 554 M	Israel
uniQure N.V. QURE	47.5	$ 10.89	-30.36 %	$ 530 M	Niderland
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
AbCellera Biologics ABCL	173	$ 3.74	3.6 %	$ 1.12 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	4.13	$ 3.36	0.86 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Agios Pharmaceuticals AGIO	47.4	$ 29.16	-3.54 %	$ 1.69 B	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Фармсинтез LIFE	209	-	-	-	Russia
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Altimmune ALT	15.1 K	$ 4.21	-2.32 %	$ 299 M	USA
Teligent, Inc. TLGT	90.7	-	-13.85 %	$ 16.1 M	USA
Evogene Ltd. EVGN	30	$ 0.84	-4.24 %	$ 27.9 M	Israel
Viela Bio, Inc. VIE	169	-	-	$ 2.91 B	USA
Amarin Corporation plc AMRN	213	$ 13.98	1.27 %	$ 5.7 B	Irlanda
AbbVie ABBV	258	$ 233.57	0.64 %	$ 413 B	USA
Blueprint Medicines Corporation BPMC	42.5	-	-	$ 8.14 B	USA
AIM ImmunoTech AIM	46	$ 0.8	-11.6 %	$ 38.5 M	USA
Aptorum Group Limited APM	20.6	$ 0.83	5.37 %	$ 4.53 M	China
Apellis Pharmaceuticals APLS	115	$ 20.67	-1.38 %	$ 2.61 B	USA